#Drug Approval

FDA Grants Leucovorin Approval for Rare Disorder Without Traditional Trial Data

The FDA's recent approval of Leucovorin for a rare disorder, lacking conventional trial data, prompts a reevaluation of drug evaluation protocols and potential impacts on infrastructure.